Abstract

BackgroundThe World Health Organization initiated test, treat, and track (T3) malaria strategy to support malaria-endemic countries in their efforts to achieve universal coverage with diagnostic testing, antimalarial treatment, and strengthening surveillance systems. Unfortunately, T3 is not adopted by over-the-counter medicine sellers (OTCMS) where many patients with malaria-like symptoms first seek treatment. Sub-Saharan African countries are considering introducing and scaling up RDTs in these outlets to reduce malaria burden. In this context, this study is aimed at improving implementation of the T3 among OTCMS using a number of intervention tools that could be scaled-up easily at the national level.Methods/designThe interventions will be evaluated using a two-arm, cluster randomized trial across 8 rural communities (4 clusters per arm), in two adjacent districts (Fanteakwa North and Fanteakwa South districts) of Ghana. A total of 8 OTCMS in the intervention arm and 5 OTCMS in the control arm in the selected communities will participate in the study. In the intervention arm only, subsidized malaria rapid diagnostic test (mRDT) kits will be introduced after the OTCMS have been trained on how to use the kit appropriately. Supervision, technical assistance, feedbacks, and collection of data will be provided on a regular basis at the participating medicine stores. The primary outcome is the proportion of children under 10 years with fever or suspected to have malaria visiting OTCMS and tested (using mRDT) before treatment. Secondary outcomes will include adherence to national malaria treatment guidelines and recommended mRDT retail price. Outcomes will be measured using mainly a household survey supplemented by mystery client survey and a surveillance register on malaria tests conducted by the OTCMS during patient consultations. Data collected will be double entered and verified using Microsoft Access 2010 (Microsoft Inc., Redmond, Washington) and analyzed using STATA version 11.0.DiscussionThe trial will provide evidence on the combined effectiveness of provider and community interventions in improving adherence to the T3 initiative among OTCMS in rural Ghana.Ethical clearanceNMIMR-IRB CPN 086/18-19Trial registrationISRCTN registry ISRCTN77836926. Registered on 4 November 2019.

Highlights

  • IntroductionIntroduction of malaria surveillance toolA malaria surveillance tool (see additional file 2) will be introduced to over-the-counter medicine sellers (OTCMS) at the initial training on how to use malaria rapid diagnostic test (mRDT)

  • Introduction of malaria surveillance toolA malaria surveillance tool will be introduced to over-the-counter medicine sellers (OTCMS) at the initial training on how to use malaria rapid diagnostic test (mRDT)

  • Mystery client data collection will commence in the 4th month of the intervention period

Read more

Summary

Introduction

Introduction of malaria surveillance toolA malaria surveillance tool (see additional file 2) will be introduced to OTCMS at the initial training on how to use mRDTs. Sub-Saharan African countries are considering introducing and scaling up RDTs in these outlets to reduce malaria burden In this context, this study is aimed at improving implementation of the T3 among OTCMS using a number of intervention tools that could be scaled-up at the national level. Three diagnostic tools are currently in use to detect malaria parasites in infected humans: light microscopy; nucleic acid amplification (NAA) tests, most often polymerase chain reaction (PCR) based; and rapid diagnostic test (RDT) kits. Each of these tools has advantages and disadvantages. WHO’s quest for a simple, fast, accurate, and cost-effective diagnostic test for determining the presence of malaria parasites, especially in field situations, led to the invention of malaria rapid diagnostic test (mRDT) kits [11]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.